(NYSE: ATR) Aptargroup's forecast annual revenue growth rate of 4.45% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 12.49%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.28%.
Aptargroup's revenue in 2026 is $3,777,181,000.On average, 10 Wall Street analysts forecast ATR's revenue for 2026 to be $247,540,081,075, with the lowest ATR revenue forecast at $237,883,120,825, and the highest ATR revenue forecast at $260,931,065,955. On average, 9 Wall Street analysts forecast ATR's revenue for 2027 to be $261,961,141,715, with the lowest ATR revenue forecast at $245,930,587,700, and the highest ATR revenue forecast at $282,498,277,180.
In 2028, ATR is forecast to generate $277,605,417,320 in revenue, with the lowest revenue forecast at $261,961,141,715 and the highest revenue forecast at $296,468,679,675.